JP2025505546A5 - - Google Patents
Info
- Publication number
- JP2025505546A5 JP2025505546A5 JP2024545105A JP2024545105A JP2025505546A5 JP 2025505546 A5 JP2025505546 A5 JP 2025505546A5 JP 2024545105 A JP2024545105 A JP 2024545105A JP 2024545105 A JP2024545105 A JP 2024545105A JP 2025505546 A5 JP2025505546 A5 JP 2025505546A5
- Authority
- JP
- Japan
- Prior art keywords
- receptor protein
- chimeric receptor
- domain
- cells
- genetically modified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263306514P | 2022-02-04 | 2022-02-04 | |
| US63/306,514 | 2022-02-04 | ||
| PCT/US2023/061966 WO2023150698A2 (en) | 2022-02-04 | 2023-02-03 | Chimeric ilt receptor compositions and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025505546A JP2025505546A (ja) | 2025-02-28 |
| JP2025505546A5 true JP2025505546A5 (https=) | 2026-02-10 |
Family
ID=87553009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024545105A Pending JP2025505546A (ja) | 2022-02-04 | 2023-02-03 | キメラｉｌｔ受容体組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US12269861B2 (https=) |
| EP (1) | EP4473006A4 (https=) |
| JP (1) | JP2025505546A (https=) |
| KR (1) | KR20240156654A (https=) |
| CN (1) | CN119053618A (https=) |
| AU (1) | AU2023216270A1 (https=) |
| CA (1) | CA3248806A1 (https=) |
| WO (1) | WO2023150698A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119569893B (zh) * | 2023-09-06 | 2025-10-31 | 上海恩凯细胞技术有限公司 | 特异性靶向肿瘤的嵌合抗原受体细胞及其制备方法和应用 |
| CN119569892A (zh) * | 2023-09-06 | 2025-03-07 | 上海恩凯细胞技术有限公司 | 特异性靶向肿瘤非经典hla分子的嵌合抗原受体的应用 |
| CN119569891B (zh) * | 2023-09-06 | 2025-09-05 | 上海恩凯细胞技术有限公司 | 用于癌症治疗的靶向非经典hla分子的嵌合抗原受体的应用 |
| CN120248130A (zh) * | 2023-12-28 | 2025-07-04 | 上海恩凯细胞技术有限公司 | 特异性靶向肿瘤的转基因重组免疫细胞及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201206559D0 (en) * | 2012-04-13 | 2012-05-30 | Ucl Business Plc | Polypeptide |
| EP2730588A1 (en) | 2012-11-12 | 2014-05-14 | Intelectys | Antibodies and fragments thereof raised against the alpha-3 domain of HLA-G protein, methods and means for their preparation, and uses thereof |
| CA2959821C (en) * | 2014-10-24 | 2024-10-29 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for inducing phagocytosis of MHC class I positive cells and for overcoming resistance to anti-CD47 agents/SIRPA |
| AU2017272875B2 (en) | 2016-06-03 | 2023-10-19 | Invectys | Anti HLA-G specific antibodies |
| KR20180064612A (ko) * | 2016-12-05 | 2018-06-15 | 삼성디스플레이 주식회사 | 표시 장치 |
| MX2021002316A (es) | 2018-08-31 | 2021-07-15 | Invectys SA | Receptores de antígeno quimérico frente a múltiples isoformas de hla-g. |
| US20200190163A1 (en) * | 2018-10-26 | 2020-06-18 | Lijun Wu | Humanized bcma-car-t cells |
| CA3199205A1 (en) * | 2019-03-15 | 2020-09-24 | Cartesian Therapeutics, Inc. | Anti-bcma chimeric antigen receptors |
| MX2022001711A (es) * | 2019-08-09 | 2022-05-10 | A2 Biotherapeutics Inc | Receptores en la superficie celular que responden a la perdida de heterocigosidad. |
-
2023
- 2023-02-03 WO PCT/US2023/061966 patent/WO2023150698A2/en not_active Ceased
- 2023-02-03 KR KR1020247029752A patent/KR20240156654A/ko active Pending
- 2023-02-03 AU AU2023216270A patent/AU2023216270A1/en active Pending
- 2023-02-03 JP JP2024545105A patent/JP2025505546A/ja active Pending
- 2023-02-03 US US18/164,417 patent/US12269861B2/en active Active
- 2023-02-03 CA CA3248806A patent/CA3248806A1/en active Pending
- 2023-02-03 EP EP23750451.9A patent/EP4473006A4/en active Pending
- 2023-02-03 CN CN202380026753.7A patent/CN119053618A/zh active Pending
-
2025
- 2025-02-28 US US19/067,503 patent/US20250257114A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025505546A5 (https=) | ||
| Pende et al. | The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. | |
| Koyasu et al. | Delineation of a T-cell activation motif required for binding of protein tyrosine kinases containing tandem SH2 domains. | |
| EP3472205B1 (en) | Chimeric antigen receptor | |
| GB2611448A (en) | Polypeptide useful in adoptive cell therapy | |
| JP2023527049A5 (https=) | ||
| JP2020511136A5 (https=) | ||
| CN112074279A (zh) | 人源化bcma抗体和bcma-car-t细胞 | |
| JP2020114264A5 (https=) | ||
| CN112029001A (zh) | 靶向nk激活性受体的嵌合抗原受体 | |
| US20200308248A1 (en) | Chimeric Natural Killer Cell Receptors and Method of Using Thereof | |
| JP2024502632A5 (https=) | ||
| KR20170092695A (ko) | 세포 | |
| KR20230095083A (ko) | Cd7 표적의 키메라 항원 수용체 및 이의 용도 | |
| JP2021512615A5 (https=) | ||
| JP2018525006A5 (https=) | ||
| RU2018109426A (ru) | Химерные антигенные рецепторы со встроенными контролируемыми функциями | |
| JP2021532742A5 (https=) | ||
| KR102659440B1 (ko) | 키메라 폴리펩티드 및 그의 세포 막 내 국재화를 변경시키는 방법 | |
| CN111542545A (zh) | Cd38定向嵌合抗原受体构建体 | |
| KR20180131557A (ko) | 면역요법에서의 tgf베타의 억제 | |
| JP2022545815A5 (https=) | ||
| US12269861B2 (en) | Chimeric ILT receptor compositions and methods | |
| KR20230137923A (ko) | 신규한 키메라 항원 수용체 및 이의 용도 | |
| Wienands et al. | Tyrosine-phosphorylated forms of Ig β, CD22, TCR ζ and HOSS are major ligands for tandem SH2 domains of Syk |